A rational insurance coverage policy for repetitive transcranial magnetic stimulation for major depression

Research output: Contribution to journalArticlepeer-review

Abstract

Although most health insurance plans do not cover repetitive transcranial magnetic stimulation (rTMS) for the treatment of major depression, coverage is increasing, with approval often granted on a case-by-case basis. Accordingly, it is important for physicians who are advocating for coverage on behalf of their patients to provide cogent arguments based on published data.Most patients presenting for rTMS have medication resistance that is beyond the Food and Drug AdministrationYapproved indication of one failed but adequate trial of an antidepressant medication. However, recent naturalistic studies lend support to the proposition that rTMS is efficacious for more medicationresistant patients.

Original languageEnglish (US)
Pages (from-to)e27-e28
JournalJournal of ECT
Volume29
Issue number2
DOIs
StatePublished - Jun 1 2013

Keywords

  • Insurance coverage
  • Major depression
  • Medication resistance
  • Naturalistic data
  • Transcranial magnetic stimulation
  • Treatment resistance

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'A rational insurance coverage policy for repetitive transcranial magnetic stimulation for major depression'. Together they form a unique fingerprint.

Cite this